CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,900 | -13.0% | 10,000 | 0.0% | 0.12% | -13.3% |
| Q2 2023 | $134,400 | -18.9% | 10,000 | 0.0% | 0.14% | -21.5% |
| Q1 2023 | $165,800 | +89039.8% | 10,000 | 0.0% | 0.17% | -19.2% |
| Q4 2022 | $186 | -99.9% | 10,000 | 0.0% | 0.21% | +29.9% |
| Q3 2022 | $128,000 | +82.9% | 10,000 | 0.0% | 0.16% | +100.0% |
| Q2 2022 | $70,000 | -15.7% | 10,000 | 0.0% | 0.08% | +3.8% |
| Q1 2022 | $83,000 | +22.1% | 10,000 | 0.0% | 0.08% | +25.4% |
| Q4 2021 | $68,000 | – | 10,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |